These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34137115)

  • 1. Effect of socioeconomic status on survival in patients with head and neck cancer.
    Weizman B; Golan N; Ronen O
    Head Neck; 2021 Oct; 43(10):3001-3009. PubMed ID: 34137115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urban and rural differences in outcomes of head and neck cancer.
    Kim JD; Firouzbakht A; Ruan JY; Kornelsen E; Moghaddamjou A; Javaheri KR; Olson RA; Cheung WY
    Laryngoscope; 2018 Apr; 128(4):852-858. PubMed ID: 28940575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment delays, race, and outcomes in head and neck cancer.
    Naghavi AO; Echevarria MI; Strom TJ; Abuodeh YA; Ahmed KA; Venkat PS; Trotti A; Harrison LB; Green BL; Yamoah K; Caudell JJ
    Cancer Epidemiol; 2016 Dec; 45():18-25. PubMed ID: 27664388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head and neck cancer-specific survival based on socioeconomic status in Asians and Pacific Islanders.
    Chu KP; Shema S; Wu S; Gomez SL; Chang ET; Le QT
    Cancer; 2011 May; 117(9):1935-45. PubMed ID: 21509771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Socioeconomic disparities in head and neck cancer survival in Germany: a causal mediation analysis using population-based cancer registry data.
    Bedir A; Abera SF; Efremov L; Hassan L; Vordermark D; Medenwald D
    J Cancer Res Clin Oncol; 2021 May; 147(5):1325-1334. PubMed ID: 33569714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Type of Treatment Facility With Overall Survival After a Diagnosis of Head and Neck Cancer.
    Carey RM; Fathy R; Shah RR; Rajasekaran K; Cannady SB; Newman JG; Ibrahim SA; Brant JA
    JAMA Netw Open; 2020 Jan; 3(1):e1919697. PubMed ID: 31977060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness Outcomes in Patients With Recurrent or Refractory Head and Neck Cancers: Retrospective Analysis of Data From a Community Oncology Database.
    Fisher MD; Fernandes AW; Olufade TO; Miller PJ; Walker MS; Fenton M
    Clin Ther; 2018 Sep; 40(9):1522-1537. PubMed ID: 30150077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head and Neck Cancer Survival Disparities by Race and Rural-Urban Context.
    Clarke JA; Despotis AM; Ramirez RJ; Zevallos JP; Mazul AL
    Cancer Epidemiol Biomarkers Prev; 2020 Oct; 29(10):1955-1961. PubMed ID: 32727721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life scores as prognostic factors of overall survival in advanced head and neck cancer: analysis of a phase III randomized trial of pemetrexed plus cisplatin versus cisplatin monotherapy.
    Urba S; Gatz J; Shen W; Hossain A; Winfree K; Koustenis A; Peterson P; Cohen EE
    Oral Oncol; 2012 Aug; 48(8):723-9. PubMed ID: 22414289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
    Chen MM; Colevas AD; Megwalu U; Divi V
    Oral Oncol; 2018 Sep; 84():71-75. PubMed ID: 30115479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of race in head and neck cancer: A meta-analysis controlling for socioeconomic status.
    Russo DP; Tham T; Bardash Y; Kraus D
    Am J Otolaryngol; 2020; 41(6):102624. PubMed ID: 32663732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Socioeconomic factors and survival in patients with non-metastatic head and neck squamous cell carcinoma.
    Xu C; Chen YP; Liu X; Tang LL; Chen L; Mao YP; Zhang Y; Guo R; Zhou GQ; Li WF; Lin AH; Sun Y; Ma J
    Cancer Sci; 2017 Jun; 108(6):1253-1262. PubMed ID: 28383806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D intake and survival and recurrence in head and neck cancer patients.
    Yokosawa EB; Arthur AE; Rentschler KM; Wolf GT; Rozek LS; Mondul AM
    Laryngoscope; 2018 Nov; 128(11):E371-E376. PubMed ID: 29756240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse respiratory outcomes among head and neck cancer survivors in the Utah Cancer Survivors Study.
    Kawakita D; Abdelaziz S; Chen Y; Rowe K; Snyder J; Fraser A; Smith K; Herget K; Deshmukh V; Newman M; Monroe M; Hashibe M
    Cancer; 2020 Feb; 126(4):879-885. PubMed ID: 31721181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esophageal squamous cell neoplasia is an independent negative prognostic factor for head and neck cancer patients.
    Hamada Y; Mizuno T; Tanaka K; Katsurahara M; Horiki N; Yamada R; Inoue H; Takei Y; Katayama N
    Int J Clin Oncol; 2018 Apr; 23(2):243-248. PubMed ID: 29063984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Socioeconomic and Demographic Variation in Insurance Coverage Among Patients With Head and Neck Cancer After the Affordable Care Act.
    Panth N; Barnes J; Sethi RKV; Varvares MA; Osazuwa-Peters N
    JAMA Otolaryngol Head Neck Surg; 2019 Dec; 145(12):1144-1149. PubMed ID: 31670798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Academic Affiliation and Surgical Volume Predict Survival in Head and Neck Cancer Patients Receiving Surgery.
    Farquhar DR; Masood MM; Lenze NR; Sheth S; Patel SN; Lumley C; Zanation AM; Weissler MC; Olshan AF; Hackman TG
    Laryngoscope; 2021 Feb; 131(2):E479-E488. PubMed ID: 32449832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second Primary Non-Small-Cell Lung Cancer After Head and Neck Cancer: A Population-Based Study of Clinical and Pathologic Characteristics and Survival Outcomes in 3597 Patients.
    Budnik J; DeNunzio NJ; Singh DP; Milano MT
    Clin Lung Cancer; 2020 May; 21(3):195-203. PubMed ID: 30914310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Nonsteroidal Anti-inflammatory Drug Use With Survival in Patients With Squamous Cell Carcinoma of the Head and Neck Treated With Chemoradiation Therapy.
    Iovoli AJ; Hermann GM; Ma SJ; Platek AJ; Farrugia MK; Yau E; Wooten KE; Arshad H; Gupta V; Kuriakose MA; Hicks WL; Singh AK
    JAMA Netw Open; 2020 Jun; 3(6):e207199. PubMed ID: 32602907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival impact and toxicity of metformin in head and neck cancer: An analysis of the SEER-Medicare dataset.
    Stokes WA; Eguchi M; Amini A; Hararah MK; Ding D; McDermott JD; Bradley CJ; Karam SD
    Oral Oncol; 2018 Sep; 84():12-19. PubMed ID: 30115470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.